$4.60 Million in Sales Expected for Viveve Medical Inc (VIVE) This Quarter

Wall Street brokerages expect Viveve Medical Inc (NASDAQ:VIVE) to announce sales of $4.60 million for the current quarter, Zacks reports. Four analysts have provided estimates for Viveve Medical’s earnings, with the lowest sales estimate coming in at $4.37 million and the highest estimate coming in at $4.92 million. Viveve Medical reported sales of $4.07 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 13%. The firm is scheduled to issue its next earnings results on Wednesday, November 14th.

On average, analysts expect that Viveve Medical will report full-year sales of $21.61 million for the current financial year, with estimates ranging from $20.88 million to $22.17 million. For the next fiscal year, analysts forecast that the business will report sales of $32.39 million per share, with estimates ranging from $29.12 million to $33.95 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Viveve Medical.

Viveve Medical (NASDAQ:VIVE) last released its quarterly earnings results on Thursday, August 9th. The company reported ($0.37) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.38) by $0.01. Viveve Medical had a negative return on equity of 551.85% and a negative net margin of 239.33%. The firm had revenue of $5.53 million during the quarter, compared to analysts’ expectations of $4.97 million.

Separately, ValuEngine raised Viveve Medical from a “hold” rating to a “buy” rating in a report on Monday, July 2nd. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $9.20.

A number of hedge funds have recently added to or reduced their stakes in VIVE. Acuta Capital Partners LLC increased its stake in shares of Viveve Medical by 58.1% in the 1st quarter. Acuta Capital Partners LLC now owns 685,215 shares of the company’s stock valued at $2,508,000 after buying an additional 251,796 shares during the period. Spark Investment Management LLC acquired a new stake in shares of Viveve Medical in the 1st quarter valued at $208,000. RTW Investments LP increased its stake in shares of Viveve Medical by 11.9% in the 2nd quarter. RTW Investments LP now owns 2,861,023 shares of the company’s stock valued at $7,782,000 after buying an additional 303,464 shares during the period. Wexford Capital LP increased its stake in shares of Viveve Medical by 152.5% in the 1st quarter. Wexford Capital LP now owns 698,200 shares of the company’s stock valued at $2,555,000 after buying an additional 421,700 shares during the period. Finally, LMR Partners LLP acquired a new stake in shares of Viveve Medical in the 2nd quarter valued at $112,000. 61.95% of the stock is owned by hedge funds and other institutional investors.

VIVE stock traded down $0.23 during midday trading on Wednesday, reaching $3.10. 196,500 shares of the company’s stock traded hands, compared to its average volume of 377,541. Viveve Medical has a 1-year low of $1.60 and a 1-year high of $6.00. The stock has a market capitalization of $102.02 million, a price-to-earnings ratio of -1.47 and a beta of -0.30. The company has a debt-to-equity ratio of 3.42, a current ratio of 4.41 and a quick ratio of 4.00.

About Viveve Medical

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.

Further Reading: Average Daily Trade Volume – What You Need to Know

Get a free copy of the Zacks research report on Viveve Medical (VIVE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Viveve Medical (NASDAQ:VIVE)

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply